Bullous Pemphigoid Associated with Erythrodermic Psoriasis: A Case Report

被引：1

作者：

Chen, Wenjuan ^{[1
,2
]}

Peng, Chen ^{[1
,2
]}

Zheng, Jianfeng ^{[1
,2
]}

Lu, Xiya ^{[1
,2
]}

Ding, Yangfeng ^{[1
,2
,3
]}

Su, Lina ^{[1
,2
,3
]}

机构：

[1] Tongji Univ, Shanghai Skin Dis Hosp, Dept Dermatol, Sch Med, Shanghai, Peoples R China

[2] Tongji Univ, Inst Psoriasis, Sch Med, Shanghai, Peoples R China

[3] Tongji Univ, Shanghai Skin Dis Hosp, Dept Dermatol, Sch Med, 1278 Baode Rd, Shanghai 200443, Peoples R China

来源：

CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY | 2022年 / 15卷

基金：

中国国家自然科学基金;

关键词：

bullous pemphigoid; erythrodermic psoriasis; comorbidity; DISEASES;

D O I：

10.2147/CCID.S374556

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Psoriasis is an immune-mediated systemic disease with multiple organs involvement, such as cardiovascular, live, gut, endocrine, and so on. Bullous pemphigoid (BP) is a rare comorbidity associated with psoriasis, while BP occurring in erythrodermic psoriasis (EP) is very rare. In this case, we reported a woman with severe EP who developed BP, in whom beta hemolytic streptococcus infection was a possible triggering factor. The complicated condition of such patients needs to draw attention of the physician and study further for better treatment.

引用

页码：1805 / 1808

页数：4

共 12 条

[1] Guselkumab-associated bullous pemphigoid in a psoriasis patient: A case report and review of the literature
Burlando, Martina
Capurro, Niccolo
Herzum, Astrid
Cozzani, Emanuele
Parodi, Aurora
[J]. DERMATOLOGIC THERAPY, 2022, 35 (01)
[2] IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid
Chakievska, Lenche
Holtsche, Maike M.
Kuenstner, Axel
Goletz, Stephanie
Petersen, Britt-Sabina
Thaci, Diamant
Ibrahim, Saleh M.
Ludwig, Ralf J.
Franke, Andre
Sadik, Christian D.
Zillikens, Detlef
Hoelscher, Christoph
Busch, Hauke
Schmidt, Enno
[J]. JOURNAL OF AUTOIMMUNITY, 2019, 96 : 104 - 112
[3] The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study
Damiani, Giovanni
Bragazzi, Nicola Luigi
Karimkhani Aksut, Chante
Wu, Dongze
Alicandro, Gianfranco
McGonagle, Dennis
Guo, Cui
Dellavalle, Robert
Grada, Ayman
Wong, Priscilla
La Vecchia, Carlo
Tam, Lai-Shan
Cooper, Kevin D.
Naghavi, Mohsen
[J]. FRONTIERS IN MEDICINE, 2021, 8
[4] Pemphigoid Diseases as a Sign of Active Psoriasis: A Case Report and Brief Review
Iskandarli, Mehdi
Turk, Bengu Gerceker
Yaman, Banu
Ozturk, Gunseli
[J]. DERMATOLOGY, 2015, 231 (04) : 319 - 321
[5] Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid
Kamata, Masahiro
Asano, Yoshihide
Shida, Rino
Maeda, Narumi
Yoshizaki, Ayumi
Miyagaki, Tomomitsu
Kawashima, Tomohiko
Tada, Yayoi
Sato, Shinichi
[J]. JOURNAL OF DERMATOLOGY, 2019, 46 (06) : E216 - E217
[6] The Bidirectional Association Between Bullous Pemphigoid and Psoriasis: A Population-Based Cohort Study
Kridin, Khalaf
Ludwig, Ralf J.
Schonmann, Yochai
Damiani, Giovanni
Cohen, Arnon D.
[J]. FRONTIERS IN MEDICINE, 2020, 7
[7] Psoriasis and basement-membrane laminin
McFadden, J. P.
Powles, A.
Kimber, I.
Fry, L.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (03) : 718 - 719
[8] Bullous Pemphigoid: Trigger and Predisposing Factors
Moro, Francesco
Fania, Luca
Sinagra, Jo Linda Maria
Salemme, Adele
Di Zenzo, Giovanni
[J]. BIOMOLECULES, 2020, 10 (10) : 1 - 29
[9] Development of bullous pemphigoid during treatment of psoriatic onycho-pachydermo periostitis with ustekinumab
Nakayama, Chihiro
Fujita, Yasuyuki
Watanabe, Mika
Shimizu, Hiroshi
[J]. JOURNAL OF DERMATOLOGY, 2015, 42 (10) : 996 - 998
[10] Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: A series of 145 cases
Ohata, Chika
Ishii, Norito
Koga, Hiroshi
Fukuda, Shunpei
Tateishi, Chiharu
Tsuruta, Daisuke
Furumura, Minao
Hashimoto, Takashi
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (01) : 50 - 55

← 1 2 →